Outcomes of combined carbazochrome sodium sulfonate plus tranexamic acid therapy versus tranexamic acid monotherapy in traumatic brain injury: a retrospective cohort study in Japan | Synapse
March 3, 2026Open Access
Outcomes of combined carbazochrome sodium sulfonate plus tranexamic acid therapy versus tranexamic acid monotherapy in traumatic brain injury: a retrospective cohort study in Japan
Key Points
Combined carbazochrome sodium sulfonate and tranexamic acid therapy shows improved outcomes in traumatic brain injury patients.
The analysis found significant benefits, particularly in patients receiving the combination therapy, suggesting a stronger clinical effect.
Retrospective cohort study design was employed, analyzing data from trauma cases in a Japanese healthcare setting.
These findings indicate potential advantages of combination therapy, but further validation in clinical settings is needed.